The ADAs 2025 guidance on pharmacologic approaches to glycemic treatment emphasizes patient-specific titration, pausing or stepping down during significant nausea, vomiting, or dehydration, then re-advancing once symptoms settle and glucose trends are stable
review response
The results showed that DOV 102,677, the triple monoamine uptake inhibitor, dose-dependently reduced the voluntary consumption of ethanol by up to 71.2% over the course of the treatment period
Anytime you have a higher dose of a medication, more side effects are likely, she explains
Before leaving, youll have clear next steps and a roadmap for success
Here are some potential interactions to consider: Digestive System Issues : Both medications can cause stomach-related side effects